Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis

DOI record: { "DOI": "10.1016/j.heliyon.2023.e20153", "ISSN": [ "2405-8440" ], "URL": "http://dx.doi.org/10.1016/j.heliyon.2023.e20153", "alternative-id": [ "S2405844023073619" ], "article-number": "e20153", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis" }, { "label": "Journal Title", "name": "journaltitle", "value": "Heliyon" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.heliyon.2023.e20153" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2023 The Authors. Published by Elsevier Ltd." } ], "author": [ { "affiliation": [], "family": "Chen", "given": "Zhaoyan", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-5187-0386", "affiliation": [], "authenticated-orcid": false, "family": "Tian", "given": "Fangyuan", "sequence": "additional" } ], "container-title": "Heliyon", "container-title-short": "Heliyon", "content-domain": { "crossmark-restriction": true, "domain": [ "cell.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2023, 9, 15 ] ], "date-time": "2023-09-15T10:15:27Z", "timestamp": 1694772927000 }, "deposited": { "date-parts": [ [ 2023, 11, 27 ] ], "date-time": "2023-11-27T20:52:22Z", "timestamp": 1701118342000 }, "indexed": { "date-parts": [ [ 2023, 11, 28 ] ], "date-time": "2023-11-28T00:40:18Z", "timestamp": 1701132018029 }, "is-referenced-by-count": 0, "issue": "9", "issued": { "date-parts": [ [ 2023, 9 ] ] }, "journal-issue": { "issue": "9", "published-print": { "date-parts": [ [ 2023, 9 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 9, 1 ] ], "date-time": "2023-09-01T00:00:00Z", "timestamp": 1693526400000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 12, "start": { "date-parts": [ [ 2023, 9, 13 ] ], "date-time": "2023-09-13T00:00:00Z", "timestamp": 1694563200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2405844023073619?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2405844023073619?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "e20153", "prefix": "10.1016", "published": { "date-parts": [ [ 2023, 9 ] ] }, "published-print": { "date-parts": [ [ 2023, 9 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1038/s41562-022-01450-3", "article-title": "Life expectancy changes since COVID-19", "author": "Schöley", "doi-asserted-by": "crossref", "first-page": "1649", "issue": "12", "journal-title": "Nat. Human Behav.", "key": "10.1016/j.heliyon.2023.e20153_bib1", "volume": "6", "year": "2022" }, { "DOI": "10.1002/jmv.27940", "article-title": "Safety and efficacy of COVID-19 vaccines in children and adolescents: a systematic review of randomized controlled trials", "author": "Tian", "doi-asserted-by": "crossref", "first-page": "4644", "issue": "10", "journal-title": "J. Med. Virol.", "key": "10.1016/j.heliyon.2023.e20153_bib2", "volume": "94", "year": "2022" }, { "key": "10.1016/j.heliyon.2023.e20153_bib3", "unstructured": "WHO. Coronavirus disease COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed January 12, 2023.." }, { "article-title": "COVID-19: how Omicron overtook Delta in three charts", "author": "Mallapaty", "journal-title": "Nature", "key": "10.1016/j.heliyon.2023.e20153_bib4", "year": "2022" }, { "DOI": "10.1126/science.abq1841", "article-title": "Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure", "author": "Reynolds", "doi-asserted-by": "crossref", "issue": "6603", "journal-title": "Science", "key": "10.1016/j.heliyon.2023.e20153_bib5", "volume": "377", "year": "2022" }, { "DOI": "10.1016/S2213-2600(22)00127-8", "article-title": "Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study", "doi-asserted-by": "crossref", "first-page": "761", "issue": "8", "journal-title": "Lancet Respir. Med.", "key": "10.1016/j.heliyon.2023.e20153_bib6", "volume": "10", "year": "2022" }, { "DOI": "10.1016/S2213-2600(22)00126-6", "article-title": "Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study", "author": "Huang", "doi-asserted-by": "crossref", "first-page": "863", "issue": "9", "journal-title": "Lancet Respir. Med.", "key": "10.1016/j.heliyon.2023.e20153_bib7", "volume": "10", "year": "2022" }, { "DOI": "10.1038/s41591-022-02051-3", "article-title": "Acute and postacute sequelae associated with SARS-CoV-2 reinfection", "author": "Bowe", "doi-asserted-by": "crossref", "first-page": "2398", "issue": "11", "journal-title": "Nat. Med.", "key": "10.1016/j.heliyon.2023.e20153_bib8", "volume": "28", "year": "2022" }, { "DOI": "10.1001/jama.2022.18931", "article-title": "Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021", "author": "Wulf Hanson", "doi-asserted-by": "crossref", "first-page": "1604", "issue": "16", "journal-title": "JAMA", "key": "10.1016/j.heliyon.2023.e20153_bib9", "volume": "328", "year": "2022" }, { "DOI": "10.1016/j.ijantimicag.2023.106870", "article-title": "Efficacy and safety of molnupiravir treatment for COVID-19: a systematic review and meta-analysis of randomized controlled trials", "author": "Tian", "doi-asserted-by": "crossref", "issue": "2", "journal-title": "Int. J. Antimicrob. Agents", "key": "10.1016/j.heliyon.2023.e20153_bib10", "volume": "62", "year": "2023" }, { "DOI": "10.1002/jmv.28732", "article-title": "Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: a systematic review and meta-analysis", "author": "Tian", "doi-asserted-by": "crossref", "issue": "4", "journal-title": "J. Med. Virol.", "key": "10.1016/j.heliyon.2023.e20153_bib11", "volume": "95", "year": "2023" }, { "DOI": "10.1038/d41573-020-00016-0", "article-title": "Therapeutic options for the 2019 novel coronavirus (2019-nCoV)", "author": "Li", "doi-asserted-by": "crossref", "first-page": "149", "issue": "3", "journal-title": "Nat. Rev. Drug Discov.", "key": "10.1016/j.heliyon.2023.e20153_bib12", "volume": "19", "year": "2020" }, { "DOI": "10.3390/v13081585", "article-title": "Non-nucleotide RNA-dependent RNA polymerase inhibitor that blocks SARS-CoV-2 replication", "author": "Dejmek", "doi-asserted-by": "crossref", "first-page": "1585", "issue": "8", "journal-title": "Viruses", "key": "10.1016/j.heliyon.2023.e20153_bib13", "volume": "13", "year": "2021" }, { "DOI": "10.1038/s41579-021-00630-8", "article-title": "Structural biology of SARS-CoV-2 and implications for therapeutic development", "author": "Yang", "doi-asserted-by": "crossref", "first-page": "685", "issue": "11", "journal-title": "Nat. Rev. Microbiol.", "key": "10.1016/j.heliyon.2023.e20153_bib14", "volume": "19", "year": "2021" }, { "DOI": "10.1038/s41392-020-00351-z", "article-title": "Azvudine (FNC): a promising clinical candidate for COVID-19 treatment", "author": "Yu", "doi-asserted-by": "crossref", "first-page": "236", "issue": "1", "journal-title": "Signal Transduct. Targeted Ther.", "key": "10.1016/j.heliyon.2023.e20153_bib15", "volume": "5", "year": "2020" }, { "DOI": "10.1136/bmj.d5928", "article-title": "Cochrane bias methods group; Cochrane statistical methods group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials", "author": "Higgins", "doi-asserted-by": "crossref", "first-page": "d5928", "journal-title": "BMJ", "key": "10.1016/j.heliyon.2023.e20153_bib16", "volume": "343", "year": "2011" }, { "DOI": "10.21203/rs.3.rs-2273657/v1", "doi-asserted-by": "crossref", "key": "10.1016/j.heliyon.2023.e20153_bib17", "unstructured": "Paula Cabral, Sávio de Souza, Renato da Silva, et al. Serial Viral Load Analysis by Ddpcr to Evaluate Fnc Efficacy and Safety in the Treatment of Moderate Cases of Covid-19, 21 November 2022, PREPRINT (Version 1) available at Research Square. https://doi.org/10.21203/rs.3.rs-2273657/v1, ." }, { "author": "Cabral", "key": "10.1016/j.heliyon.2023.e20153_bib18", "series-title": "Serial Viral Load Analysis by Ddpcr to Evaluate Fnc Efficacy and Safety in the Treatment of Mild Cases of Covid-19, 21 November", "year": "2022" }, { "DOI": "10.1002/advs.202001435", "article-title": "A randomized, open-label, controlled clinical trial of azvudine tablets in the treatment of mild and common COVID-19, a pilot study", "author": "Ren", "doi-asserted-by": "crossref", "issue": "19", "journal-title": "Adv. Sci.", "key": "10.1016/j.heliyon.2023.e20153_bib19", "volume": "7", "year": "2020" }, { "key": "10.1016/j.heliyon.2023.e20153_bib20", "unstructured": "https://www1.hkexnews.hk/app/sehk/2022/104646/documents/sehk22080402059.pdf." }, { "DOI": "10.1038/d41586-022-00919-5", "article-title": "African clinical trial denied access to key COVID drug Paxlovid", "author": "Ledford", "doi-asserted-by": "crossref", "first-page": "412", "issue": "7906", "journal-title": "Nature", "key": "10.1016/j.heliyon.2023.e20153_bib21", "volume": "604", "year": "2022" }, { "DOI": "10.1038/s41392-021-00835-6", "article-title": "Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "414", "issue": "1", "journal-title": "Signal Transduct. Targeted Ther.", "key": "10.1016/j.heliyon.2023.e20153_bib22", "volume": "6", "year": "2021" }, { "article-title": "Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions", "author": "Liu", "first-page": "503", "issue": "9", "journal-title": "Pharmazie", "key": "10.1016/j.heliyon.2023.e20153_bib23", "volume": "73", "year": "2018" }, { "DOI": "10.1016/j.ejps.2017.05.009", "article-title": "Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "150", "journal-title": "Eur. J. Pharmaceut. Sci.", "key": "10.1016/j.heliyon.2023.e20153_bib24", "volume": "105", "year": "2017" } ], "reference-count": 24, "references-count": 24, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2405844023073619" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Multidisciplinary" ], "subtitle": [], "title": "Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "9" }